QNRX · Quoin Pharmaceuticals
AI read · Good for QNRX
The AI's read
A favorable rating can draw attention to Quoin and shows that Craig-Hallum sees promise in its shares. The story reports no new trial result or sales change, so this is an outside opinion, not proof of business progress.